Advances in Recurrent Stroke Prevention: Focus on Antithrombotic Therapies.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 35420910.
- Also identified by DOI 10.1161/CIRCRESAHA.121.319947 and PMC identifier 9015232.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The past decade has seen significant advances in stroke prevention. These advances include new antithrombotic agents, new options for dyslipidemia treatment, and novel techniques for surgical stroke prevention. In addition, there is greater recognition of the benefits of multifaceted interventions, including the role of physical activity and dietary modification. Despite these advances, the aging of the population and the high prevalence of key vascular risk factors pose challenges to reducing the burden of stroke. Using a cause-based framework, current approaches to prevention of cardioembolic, cryptogenic, atherosclerotic, and small vessel disease stroke are outlined in this paper. Special emphasis is given to recent trials of antithrombotic agents, including studies that have tested combination treatments and responses according to genetic factors.
Medical subject headings
- Fibrinolytic Agents
- Stroke